Surgery Partners, Inc. (SGRY) has a consensus analyst rating of Buy, based on 22 analysts covering the stock. Of those, 14 recommend buying, 8 recommend holding, and 0 recommend selling.
The analyst consensus price target for SGRY is $18.85, representing a +43.9% upside from the current price of $13.1. Price targets range from a low of $16.25 to a high of $21.00.
